[Prevalence of anti-rubella and anti-parvovirus B19 antibodies in pregnant women in the city of Córdoba, and in women of fertile age in the city of Villa Mercedes, province of San Luis].
We determined the prevalence of anti-rubella antibodies in 100 serum samples from pregnant women who attended routine examination at a private institution in the city of Córdoba, and in 100 serum samples from women of gestational age, 42 of whom were pregnant, attending health centres in the city of Villa Mercedes, province of San Luis. IgG antibodies against parvovirus 819 were also determined in the serum samples from Córdoba. Using the hemmagglutination inhibition test, we found a 98% prevalence of anti-rubella antibodies among pregnant women in Córdoba and of 96% among the women in Villa Mercedes, whereas the prevalence of anti-parvovirus 819 was 66% in the serum samples from Cordoba. These results coincide with those reported for other cities in the world, and establish an interest in continuing similar studies in order to monitor the immunization plan, which in Argentina has been going on since 1997. They also suggest the importance of the determination of IgM anti-parvovirus B19 in pregnant women who are symptomatic but with a negative result for rubella.
Pedranti
M S
MS
Laboratorio de Inmunología del Instituto de Virología "J. M. Vanella", Facultad de Ciencias Médicas, Universidad Nacional de Córdoba, Enfermera Gordillo Gómez s/n, Ciudad Universitaria (5016), Argentina. mauropedranti@hotmail.com
Adamo
M P
MP
Macedo
R
R
Zapata
M T
MT
D000293:Adolescent; D000328:Adult; D000914:Antibodies, Viral / Q000097:blood*; D001118:Argentina; D002648:Child; D005260:Female; D006801:Humans; D016732:Parvovirus B19, Human / Q000276:immunology*; D011247:Pregnancy; D015995:Prevalence; D016036:Seroepidemiologic Studies; D014505:Urban Population
D000914:Antibodies, Viral; C040901:rubella antibodies